What is Arcutis Biotherapeutics, Inc.'s EV / EBITDA?

Arcutis Biotherapeutics, Inc. (ARQT) reported EV / EBITDA of 125.8× in Q2 2024.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Arcutis Biotherapeutics, Inc. ARQT EV / EBITDA

EV / EBITDA at other companies

PfizerPFE

12.9×—

AmgenAMGN

15.9×-1.3×

IncyteINCY

9×-28.2×

OrganonOGN

8×-1.0×

Ligand PharmaceuticalsLGND

30.3×—

TG TherapeuticsTGTX

37.5×-67.9×

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.29B+57.5%

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.

enterprise value/ebitda=125.8×

Based on the most recent quarter.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s EV / EBITDA?: Arcutis Biotherapeutics, Inc. (ARQT) reported EV / EBITDA of 125.8× in Q2 2024.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.